Oppenheimer analyst Ling Wang reiterated an Outperform rating and $26 price target on Rockwell Medical Technologies (NASDAQ: RMTI) following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE